DK102857C - Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener. - Google Patents

Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener.

Info

Publication number
DK102857C
DK102857C DK232161A DK232161A DK102857C DK 102857 C DK102857 C DK 102857C DK 232161 A DK232161 A DK 232161A DK 232161 A DK232161 A DK 232161A DK 102857 C DK102857 C DK 102857C
Authority
DK
Denmark
Prior art keywords
pregnadienes
keto
trifluoromethyl
preparation
Prior art date
Application number
DK232161A
Other languages
English (en)
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of DK102857C publication Critical patent/DK102857C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK232161A 1960-06-08 1961-06-08 Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener. DK102857C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2019060 1960-06-08

Publications (1)

Publication Number Publication Date
DK102857C true DK102857C (da) 1965-10-18

Family

ID=10141901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK232161A DK102857C (da) 1960-06-08 1961-06-08 Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener.

Country Status (3)

Country Link
CH (1) CH401960A (da)
DK (1) DK102857C (da)
ES (1) ES268064A1 (da)

Also Published As

Publication number Publication date
CH401960A (de) 1965-11-15
ES268064A1 (es) 1961-11-16

Similar Documents

Publication Publication Date Title
DK113988B (da) Fremgangsmåde til fremstilling af 1,6-dibrom-1,6-didesoxy-D-mannitol.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK104302C (da) Fremgangsmåde til fremstilling af 4-fluor-3,20-diketo-Δ&lt;4&gt;-21-brompregnener.
DK101297C (da) Fremgangsmåde til fremstilling af 3-keto-6α-trifluormethyl-Δ&lt;1,4&gt;-pregnadiener.
DK102857C (da) Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ&lt;4,6&gt;-pregnadiener.
DK97513C (da) Fremgangsmåde til fremstilling af 3,11-dioxo-17α-hydroxy-20β,21-dinitrato-Δ&lt;4&gt;-pregnen.
DK98239C (da) Fremgangsmåde til fremstilling af 2-alkoxy-3,17-diketo-11β-hydroxy-Δ&lt;1,4&gt;-androstadiener.
DK101056C (da) Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ&lt;1,4,6&gt;-pregnatriener.
DK100230C (da) Fremgangsmåde til fremstilling af 3-amino-17β-acyloxy-Δ&lt;1,3,5(10),9(11)&gt;-estratetraener.
DK96739C (da) Fremgangsmåde til fremstilling af 3-keto-17β-hydroxy-17α-ethynyl-Δ&lt;5(10),9(11)&gt;-estradien.
DK100614C (da) Fremgangsmåde til fremstilling af 3-amino-17β-acyloxy-Δ&lt;1,3,5(10)9(11)&gt;-estratetraener.
DK100166C (da) Fremgangsmåde til fremstilling af 3,20-diketo-17α-hydroxy-21-acetoxy-16α-methyl-Δ&lt;4,9(11)&gt;-pregnadien.
DK96053C (da) Fremgangsmåde til fremstilling af Δ&lt;1,4&gt;-3-ketosteroider.
DK97823C (da) Fremgangsmåde til fremstilling af 3-alkoksy-Δ&lt;3,5&gt;-pregnadienforbindelser.
DK99567C (da) Fremgangsmåde til fremstilling af 4-oxa-tetracyclo-(6:2:1:0&lt;2,7&gt;:0&lt;3,5&gt;)-hendecanderivater.
DK94561C (da) Fremgangsmåde til fremstilling af 3-acyloxy-2,4,6-pregnatrienforbindelser.
DK98001C (da) Fremgangsmåde til fremstilling af 3-oxo-14-hydroxy-11α,19-diacetoxy-(1,4)-cardadienolid.
DK97819C (da) Fremgangsmåde til fremstilling af 1-metyl-17α-alkyl- eller 17α-vinyl-Δ&lt;1&gt;-androsten-17β-ol-3-oner.
DK98177C (da) Fremgangsmåde til fremstilling af 11β,18-oxido-methyl-3,20-diketo-δ&lt;4&gt;-pregnen.
DK104404C (da) Fremgangsmåde til fremstilling af 10-alkenyl-δ&lt;1,4&gt;-3-keto-steroider.
DK108858C (da) Fremgangsmåde til fremstilling af 19-hydroxy- eller 19-acyloxy-Δ&lt;4,6&gt;-3-oxo-steroider.
DK97939C (da) Fremgangsmåde til fremstilling af 3,11,20-trioxo-18-nor-Δ&lt;4&gt;-pregnen.
DK98496C (da) Fremgangsmåde til fremstilling af 6-halogen-1,2α-metylen-Δ&lt;6&gt;-17α-acyloksyprogesteroner.
DK112870B (da) Fremgangsmåde til fremstilling af 17α-metyl-Δ&lt;1,4&gt;-androstadien-17β-ol-3-on.
DK103076C (da) Fremgangsmåde til fremstilling af derivater af 5,6-dihydro-pyridoner.